èšåºæ®µéã®ã²ãã ç·šéäŒæ¥ã§ãã Editas Medicine, Inc. ã¯ãããŸããŸãªé節ãªçŸæ£ãæ²»çããããã®é©æ°çãªã²ãã å»è¬åã®éçºã«æ³šåããŠããŸããå瀟ã¯ãéºäŒçã«å¯ŸåŠå¯èœãªçŸæ£ãšæ²»çé åãã¿ãŒã²ãããšãã CRISPR æè¡ã«åºã¥ãç¬èªã®ã²ãã ç·šéãã©ãããã©ãŒã ãéçºããŠããŸããå瀟ã¯ãå°å
æã®å€±æã«ã€ãªããéºäŒæ§ã®èŠååªå€±ã§ããã¬ãŒããŒå
倩æ§é»å
é 10 åã®æ²»çè¬ãšã㊠EDIT-101 ãéçºããŠãããããã¯ãã§ãŒãº 1/2 ã®èšåºè©Šéšäžã§ããå瀟ã¯ãŸããé£èŽã䌎ãç¶²èè²çŽ å€æ§çã®äžçš®ã§ããã¢ãã·ã£ãŒçå矀 2A ã®æ²»çè¬ãšã㊠EDIT-102ãé²è¡æ§ã®ç¶²è倿§ã§ããåžžæè²äœåªæ§ç¶²èè²çŽ å€æ§ç 4ãéç¶èµ€è¡ççãšããŒã¿ãµã©ã»ãã¢ã®æ²»çè¬ãšã㊠EDIT-301 ãéçºããŠããŸããããã«ãå瀟ã¯åºåœ¢è
«çã®æ²»çè¬ãšããŠéºäŒåç·šéãããããã¥ã©ã« ãã©ãŒçްèå»è¬åãè€æ°ã®ãããæ²»çããã¢ã«ãã¡ããŒã¿ T 现èå瀟ã¯ããæ²»çã®ããã®ã¬ã³ããã«ã¿T现èçæ³ãéçºããŠãããç¥çµçŸæ£ã®æ²»çã®ããã®æ²»çæ³éçºã®ããã®æ©æçºèŠããã°ã©ã ã宿œããŠãããå瀟ã¯ãããçšã®éºäŒåæ¹å€T现èã®éçºã§Juno Therapeutics, Inc.ãšå
±åç ç©¶ãè¡ã£ãŠããããŸããããŸããŸãªçŒçŸæ£ã«å¯Ÿããæ°ããéºäŒåç·šéè¬ã®çºèŠãéçºãåååã§Allergan Pharmaceuticals International LimitedãšæŠç¥çææºããã³ãªãã·ã§ã³å¥çŽãçµãã§ãããããã«ãç¥çµçŸæ£ã®æ²»çã®ããã®æ²»çæ³ã®éçºã§Asklepios BioPharmaceutical, Inc.ãšå
±åç ç©¶ãè¡ã£ãŠããã»ããAskBioãšå
±åç ç©¶ãè¡ã£ãŠããã»ããm BlueRock Therapeutics LPãšãå
±åç ç©¶ãè¡ã£ãŠãããå瀟ã¯ä»¥åã¯Gengine, Inc.ãšããŠç¥ãããŠããã2013幎11æã«Editas Medicine, Inc.ã«ç€Ÿåã倿ŽãããEditas Medicine, Inc.ã¯2013幎ã«èšç«ãããããµãã¥ãŒã»ããå·ã±ã³ããªããžã«æ¬ç€Ÿã眮ããŠããã